¶¶Òô´ó¹Ï

¶¶Òô´ó¹Ï is on record  in support of legislation (H.R. 4299) that holds physician reimbursement for Part B drugs harmless from drug price negotiation.

The Senate Appropriations Committee approved its Fiscal Year (FY) 2026 Labor, Health and Human Services, and Education spending bill on July 31 by a vote of 26 to 3.

Reps. Chu and Wilson introduced the Stomach Cancer Prevention and Early Detection Act, directing NCI to review stomach cancer and recommend actions. ¶¶Òô´ó¹Ï supports, noting early detection via endoscopy can improve treatment outcomes.

¶¶Òô´ó¹Ï joined 60 groups urging HHS OIG to study how Medicare Advantage step therapy for Part B drugs affects care access, citing outdated protocols for IBD and increased use since 2018 guidance.

ACG, AGA, and ¶¶Òô´ó¹Ï previously shared an overview of CMS’ proposed payment rules for 2026. There are two specific proposals within the regulation that have significant implications.

CMS published an alert on fraud schemes targeting Medicare providers that involve bad actors impersonating CMS and sending phishing fax requests for medical records and documentation, falsely claiming to be part of a Medicare audit.

On July 15, 2025, the Centers for Medicare & Medicaid Services (CMS) released the CY 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule.

On July 14, the Centers for Medicare and Medicaid Services (CMS) released proposed payment rates for physician services for calendar year (CY) 2026. 

¶¶Òô´ó¹Ï and other organizations are asking Congress to protect the integrity of the U.S. Preventive Services Task Force. USPSTF is tasked with making evidence-based recommendations about clinical preventive services, including colorectal cancer screening.